Cite
A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study.
MLA
Ritzel, Robert, et al. “A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/ML Versus 100 Units/ML in Older People With Type 2 Diabetes: Results From the SENIOR Study.” Diabetes Care, vol. 41, no. 8, Aug. 2018, pp. 1672–80. EBSCOhost, https://doi.org/10.2337/dc18-0168.
APA
Ritzel, R., Harris, S. B., Baron, H., Florez, H., Roussel, R., Espinasse, M., Muehlen-Bartmer, I., Zhang, N., Bertolini, M., Brulle-Wohlhueter, C., Munshi, M., & Bolli, G. B. (2018). A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study. Diabetes Care, 41(8), 1672–1680. https://doi.org/10.2337/dc18-0168
Chicago
Ritzel, Robert, Stewart B Harris, Helen Baron, Hermes Florez, Ronan Roussel, Melanie Espinasse, Isabel Muehlen-Bartmer, et al. 2018. “A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/ML Versus 100 Units/ML in Older People With Type 2 Diabetes: Results From the SENIOR Study.” Diabetes Care 41 (8): 1672–80. doi:10.2337/dc18-0168.